Three years? Five? Ten?

We analyzed hundreds of anonymous compensation submissions to find out.

The results reveal two significant earnings milestones, including when earning $300K becomes more common than not.

Plus, an exclusive interview with veteran recruiter Joe McClung and the latest developments across medtech.

Medical device sales has long been considered one of the most lucrative careers in sales.

But how long does it actually take to reach the industry’s highest earning levels?

We analyzed hundreds of anonymous compensation survey submissions, comparing reported annual W-2 earnings across experience levels.

And the results reveal a clear pattern.

Among respondents with 3 to 5 years of experience, approximately 31% reported earning $200,000 or more.

But among those with 6 to 10 years of experience?

That number jumped to 59%.

By this stage, many reps have had time to develop stronger surgeon relationships, build their territories, and establish themselves within their organizations.

Others may have transitioned into higher-paying specialties or secured more lucrative positions.

While our survey doesn’t establish exactly what drives the increase, the earnings difference is substantial.

Here’s where things get even more interesting.

We looked at the percentage of respondents reporting annual W-2 compensation of $300,000 or more.

The biggest takeaway?

Among respondents with 3 to 5 years of experience, fewer than 1 in 10 reported earning $300K.

But among those with 11 to 15 years of experience, nearly 6 in 10 reached that milestone.

For many medical device professionals, $300K represents a significant financial achievement.

Our data suggests that reaching this level becomes considerably more common among respondents with more than a decade of industry experience.

But experience alone doesn’t guarantee a bigger paycheck.

Our latest compensation data suggests two major milestones:

Years 6 to 10: Earning $200K+ becomes more common than not among respondents.

Years 11 to 15: Earning $300K+ becomes more common than not.

But these aren’t guaranteed milestones.

They’re patterns emerging from our anonymous survey.

And as our dataset continues to grow, we’ll be examining how compensation differs across specialties, employers, roles, and experience levels.

The question isn’t simply how long you’ve been in medical device sales. It’s whether your experience is translating into greater earning potential.

We’re building an independent compensation resource to give medical device professionals greater transparency into what people actually earn.

Contribute anonymously and access our free compensation report.

TAKE THE ANONYMOUS COMPENSATION SURVEY

GET THE FREE COMPENSATION REPORT

A quick word from this week’s sponsor.

Looking for investment opportunities outside the stock market? Popsmith, a fast-growing consumer brand with $5.8M in 2025 revenue, is raising capital and offering individual investors the opportunity to become shareholders.

Take a look at their investment opportunity below.

What does it look like when a consumer brand starts to break out?

Popsmith generated $5.8M in revenue in 2025 and is projecting $9M in 2026, with more than 100,000 customers and $20M+ in lifetime sales.

The brand has already earned national recognition through Oprah’s Favorite Things and partnerships with Costco, Sur La Table, and Williams Sonoma, where Popsmith is rolling out nationwide this holiday season.

Now Popsmith is raising capital to accelerate its next stage of growth, and individual investors have the opportunity to become shareholders.

Explore the Popsmith investment opportunity.

What separates candidates who land competitive medical device sales positions from those who get passed over?

We recently sat down with Joe McClung, a veteran medical device industry professional and recruiting executive, to discuss hiring, compensation, and career development.

Here are three takeaways every medical device sales professional should know.

Anyone can walk into an interview and claim they’re competitive, resilient, or hardworking. Joe’s advice? Prove it with a story.

Instead of saying you’re resilient, describe a time you overcame adversity. Instead of claiming you’re competitive, explain how that competitiveness translated into measurable results. Hiring managers hear the same buzzwords every day.

The takeaway: Prepare three compelling stories that demonstrate grit, initiative, and resilience before your next interview.

A company advertises a medical device sales position with $250,000 in on-target earnings. Sounds attractive, but Joe recommends asking a much more revealing question:

“What percent of the team hits that today?”

If very few reps are achieving quota, the advertised earning potential may not reflect reality. Joe also recommends working backward from the compensation plan to determine what it would actually take to reach your income target.

The takeaway: Don’t evaluate a sales opportunity based on advertised OTE. Evaluate the probability of actually earning it.

Joe highlighted several surprisingly common interview mistakes. Candidates don’t ask thoughtful questions, they fail to follow up, and they neglect to ask for the next step.

Sound familiar? These are fundamental sales behaviors.

If you’re interviewing for a sales position, the interview itself is an opportunity to demonstrate how you sell.

The takeaway: Uncover the hiring manager’s priorities, position your experience around their needs, and ask for the next step.

We’ll be releasing video highlights from our conversation with Joe, including his insights on interview mistakes, compensation negotiations, and what medical device companies actually look for in candidates.

We’ll also be sharing his Executive Career Transition Guide as a free resource.

Two of the biggest names in orthopedic medical devices reportedly came close to combining their businesses. According to the Financial Times, the negotiations collapsed over one question:

Who would become CEO?

In reporting published October 23, the Financial Times revealed that Johnson & Johnson and Smith+Nephew had been engaged in advanced discussions to combine J&J’s DePuy Synthes orthopedic business with Smith+Nephew.

The proposed transaction would have created a medical technology company valued at approximately $34 billion. According to the report, the companies had reached an understanding on the main financial terms and transaction structure, with J&J shareholders set to own 50.1% of the combined company.

But the negotiations reportedly broke down over leadership.

J&J wanted Namal Nawana, the current head of its orthopedic business and former Smith+Nephew CEO, to lead the combined organization. Smith+Nephew reportedly insisted that its current CEO, Deepak Nath, remain in charge.

Neither company has publicly confirmed the reported negotiations.

For orthopedic sales professionals, a combination of this magnitude could have had enormous implications.

Consider the potential overlap:

Territories: Two established orthopedic sales organizations operating in many of the same hospitals and markets.

Product portfolios: Competing implants, instruments, and technologies across major orthopedic specialties.

Leadership: Regional managers, sales directors, and commercial executives with overlapping responsibilities.

Compensation: Different commission structures, quotas, incentives, and territory assignments.

A merger could have required significant decisions about how these organizations would operate together. For some representatives, that might have created new opportunities. For others, it could have introduced uncertainty surrounding territories, leadership, and compensation.

These are hypothetical implications of a potential combination, not announced changes at either company.

For now, the deal reportedly isn’t happening.

J&J previously announced plans to separate its DePuy Synthes orthopedic business. The reported Smith+Nephew negotiations highlight how significant the strategic possibilities surrounding that separation could be.

A combination of two major orthopedic competitors would have reshaped the competitive landscape. Instead, according to the Financial Times, an executive leadership disagreement reportedly brought advanced negotiations to an end.

The most interesting question may be what happens next.

Will DePuy Synthes proceed toward becoming an independent company? Could negotiations with another buyer emerge? Or could the two companies eventually revisit discussions?

For now, those questions remain unanswered.

But one thing is clear: The future of one of orthopedics’ largest businesses remains a story worth watching.

Source: Financial Times, October 23, 2026. Reported negotiations and proposed terms have not been independently confirmed by either company.

READ THE FULL FINANCIAL TIMES REPORT

Michael “Mike” Marinaro began his Medtronic career as a territory sales manager in Boston in 2000.

Twenty-six years later, he’s been named President of Medtronic, effective October 14, 2026.

Marinaro previously served as executive vice president and president of the company’s Medical Surgical Portfolio, Americas, and Global Commercial Operations. His expanded responsibilities now include oversight of Greater China, and he continues reporting to Medtronic Chairman and CEO Geoff Martha.

For medical device sales professionals, Marinaro’s career progression is worth recognizing.

He didn’t begin in the executive suite. He began in the field.

His career demonstrates how commercial experience can become a foundation for broader leadership responsibilities across a global medical technology company.

Not every successful sales representative wants to pursue management. But for those who do, his progression offers a compelling example of what’s possible.

From territory sales manager to president of Medtronic. Twenty-six years. One company.

This week’s compensation data, recruiting insights, and industry developments reinforce one important lesson: Your career trajectory depends on more than years of experience.

The company you choose, the relationships you build, and the opportunities you pursue all matter.

Don’t just accumulate years in medical device sales. Make those years count.

Forward this issue to a colleague or share it with someone considering a career in medical device sales.

We’re building an independent resource for the professionals who drive this industry forward.

THE MED DEVICE REP

Independent insights into medical device sales compensation, careers, and industry news.